236 related articles for article (PubMed ID: 15757808)
1. Clinical trial design in hepatocellular carcinoma.
Johnson PJ; Billingham LJ
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):119-27. PubMed ID: 15757808
[TBL] [Abstract][Full Text] [Related]
2. Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
[TBL] [Abstract][Full Text] [Related]
3. Re: Design and endpoints of clinical trials in hepatocellular carcinoma.
Di Maio M; Daniele B; Gallo C; Perrone F
J Natl Cancer Inst; 2008 Nov; 100(21):1557; author reply 1557-8. PubMed ID: 18957679
[No Abstract] [Full Text] [Related]
4. Key research issues in the management of hepatocellular carcinoma.
Venook AP
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S87-90. PubMed ID: 15309518
[TBL] [Abstract][Full Text] [Related]
5. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
Suman VJ; Dueck A; Sargent DJ
Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
[No Abstract] [Full Text] [Related]
7. Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III.
El-Maraghi RH; Eisenhauer EA
J Clin Oncol; 2008 Mar; 26(8):1346-54. PubMed ID: 18285606
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase II designs in cancer clinical trials: current status and future directions.
Lee JJ; Feng L
J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154
[TBL] [Abstract][Full Text] [Related]
9. A parallel phase I/II clinical trial design for combination therapies.
Huang X; Biswas S; Oki Y; Issa JP; Berry DA
Biometrics; 2007 Jun; 63(2):429-36. PubMed ID: 17688495
[TBL] [Abstract][Full Text] [Related]
10. From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside.
Sakamoto J; Morita S
Nagoya J Med Sci; 2007 Jan; 69(1-2):9-16. PubMed ID: 17378175
[TBL] [Abstract][Full Text] [Related]
11. Improving the design of phase II trials of cytostatic anticancer agents.
Stone A; Wheeler C; Barge A
Contemp Clin Trials; 2007 Feb; 28(2):138-45. PubMed ID: 16843736
[TBL] [Abstract][Full Text] [Related]
12. Clinical staging of hepatocellular carcinoma.
Meier V; Ramadori G
Dig Dis; 2009; 27(2):131-41. PubMed ID: 19546551
[TBL] [Abstract][Full Text] [Related]
13. [Clinical application of vitamin K for hepatocellular carcinoma].
Mizuta T; Ozaki I
Clin Calcium; 2007 Nov; 17(11):1693-9. PubMed ID: 17982189
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials.
Farrington P; Miller E
Methods Mol Med; 2003; 87():335-52. PubMed ID: 12958466
[No Abstract] [Full Text] [Related]
15. Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM).
Printz C
Cancer; 2009 Oct; 115(20):4646. PubMed ID: 19806596
[No Abstract] [Full Text] [Related]
16. Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there.
Llovet JM; Schwartz M; Fuster J; Bruix J
Semin Liver Dis; 2006 Aug; 26(3):248-53. PubMed ID: 16850374
[TBL] [Abstract][Full Text] [Related]
17. Prognostic prediction in patients with hepatocellular carcinoma.
Sala M; Forner A; Varela M; Bruix J
Semin Liver Dis; 2005; 25(2):171-80. PubMed ID: 15918146
[TBL] [Abstract][Full Text] [Related]
18. Controversies in staging of hepatocellular carcinoma.
Burns JM; Greene FL
J Hepatobiliary Pancreat Surg; 2005; 12(6):456-62. PubMed ID: 16365818
[TBL] [Abstract][Full Text] [Related]
19. Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls.
Abdel-Rahman SM; Reed MD; Wells TG; Kearns GL
Clin Pharmacol Ther; 2007 Apr; 81(4):483-94. PubMed ID: 17329988
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hepatocellular carcinoma.
Blum HE
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
